| pubmed-article:15611808 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15611808 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15611808 | lifeskim:mentions | umls-concept:C0029246 | lld:lifeskim |
| pubmed-article:15611808 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:15611808 | lifeskim:mentions | umls-concept:C0024117 | lld:lifeskim |
| pubmed-article:15611808 | lifeskim:mentions | umls-concept:C0242800 | lld:lifeskim |
| pubmed-article:15611808 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
| pubmed-article:15611808 | lifeskim:mentions | umls-concept:C2698651 | lld:lifeskim |
| pubmed-article:15611808 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:15611808 | pubmed:dateCreated | 2004-12-21 | lld:pubmed |
| pubmed-article:15611808 | pubmed:abstractText | There are no published studies that have assessed whether adding long-acting beta 2-agonist bronchodilators and/or inhaled steroids to chronic therapy with tiotropium would provide additional clinical benefit to patients with moderate to severe chronic obstructive pulmonary disease (COPD). | lld:pubmed |
| pubmed-article:15611808 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15611808 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15611808 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15611808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15611808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15611808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15611808 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15611808 | pubmed:issn | 1198-2241 | lld:pubmed |
| pubmed-article:15611808 | pubmed:author | pubmed-author:BourbeauJeanJ | lld:pubmed |
| pubmed-article:15611808 | pubmed:author | pubmed-author:AaronShawn... | lld:pubmed |
| pubmed-article:15611808 | pubmed:author | pubmed-author:FergussonDean... | lld:pubmed |
| pubmed-article:15611808 | pubmed:author | pubmed-author:FitzgeraldMar... | lld:pubmed |
| pubmed-article:15611808 | pubmed:author | pubmed-author:GoldsteinRoge... | lld:pubmed |
| pubmed-article:15611808 | pubmed:author | pubmed-author:VandemheenKat... | lld:pubmed |
| pubmed-article:15611808 | pubmed:author | pubmed-author:BalterMeyerM | lld:pubmed |
| pubmed-article:15611808 | pubmed:author | pubmed-author:McIvorAndrewA | lld:pubmed |
| pubmed-article:15611808 | pubmed:author | pubmed-author:MaltaisFranco... | lld:pubmed |
| pubmed-article:15611808 | pubmed:author | pubmed-author:O'donnellDeni... | lld:pubmed |
| pubmed-article:15611808 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15611808 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:15611808 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15611808 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15611808 | pubmed:pagination | 581-5 | lld:pubmed |
| pubmed-article:15611808 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:meshHeading | pubmed-meshheading:15611808... | lld:pubmed |
| pubmed-article:15611808 | pubmed:articleTitle | The Canadian Optimal Therapy of COPD Trial: design, organization and patient recruitment. | lld:pubmed |
| pubmed-article:15611808 | pubmed:affiliation | The Ottawa Health Research Institute, University of Ottawa, Ottawa, Canada. saaron@ottawahospital.on.ca | lld:pubmed |
| pubmed-article:15611808 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15611808 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15611808 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15611808 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15611808 | lld:pubmed |
